Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome

Developmental Disabilities Research Reviews

Volumn 14, Issue 1, 2008, Pages 59-68

  Gothelf, Doron ^a,b   Schaer, Marie ^c,d   Eliez, Stephan ^c,e  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d EPFL   (Switzerland)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

22q11.2 deletion syndrome; Brain development; COMT; Cortical shape; Functional MRI; Neuroanatomy; Psychiatric disorders; Psychosis

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE;

ATTENTION; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN REGION; COGNITION; ENVIRONMENTAL FACTOR; FRONTAL LOBE; GENE DELETION; GENETIC RISK; GENOTYPE; HUMAN; LONGITUDINAL STUDY; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; QUALITATIVE RESEARCH; REVIEW; RISK FACTOR; TEMPORAL LOBE; THICKNESS; VELOCARDIOFACIAL SYNDROME; WHITE MATTER;

EID: 44149125060     PISSN: 19405510     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddrr.9     Document Type: Review

References (114)

1. Andersson F, Glaser B, Spiridon M, et al. 2008. Impaired activation of face processing networks revealed by functional magnetic resonance imaging in 22q11.2 deletion syndrome. Biol Psychiatry 63: 49–57.
2. Aneja A, Fremont WP, Antshel KM, et al. 2007. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol 17: 105–114.
3. Antshel KM, Aneja A, Strunge L, et al. 2007. Autistic spectrum disorders in velo‐cardio‐ facial syndrome (22q11.2 deletion). J Autism Dev Disord 37: 1776–1786.
4. Antshel KM, Conchelos J, Lanzetta G, et al. 2005. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome). Psychiatry Res 138: 235–245.
5. Antshel KM, Fremont W, Roizen NJ, et al. 2006. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 45: 596–603.
6. Arinami T, Ohtsuki T, Takase K, et al. 2001. Screening for 22q11 deletions in a schizophrenia population. Schizophr Res 52: 167–170.
7. Arnold PD, Siegel‐Bartelt J, Cytrynbaum C, et al. 2001. Velo‐cardio‐facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet 105: 354–362.
8. Baker K, Baldeweg T, Sivagnanasundaram S, et al. 2005. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry 58: 23–31.
9. Baker KD, Skuse DH. 2005. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at‐risk group. Br J Psychiatry 186: 115–120.
10. Barkovich AJ, Rowley H, Bollen A. 1995. Correlation of prenatal events with the development of polymicrogyria. AJNR Am J Neuroradiol 16 ( 4 Suppl): 822–827.
11. Barnea‐Goraly N, Eliez S, Hedeus M, et al. 2003. White matter tract alterations in fragile X syndrome: preliminary evidence from diffusion tensor imaging. Am J Med Genet B Neuropsychiatr Genet 118: 81–88.
12. Barnea‐Goraly N, Eliez S, Menon V, et al. 2005. Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome. Brain Res Cogn Brain Res 25: 735–740.
13. Bassett AS, Caluseriu O, Weksberg R, et al. 2007. Catechol‐ O ‐methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 61: 1135–1140.
14. Bassett AS, Chow EW, Abdel Malik P, et al. 2003. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 160: 1580–1586.
15. Bassett AS, Hodgkinson K, Chow EW, et al. 1998. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 81: 328–337.
16. Bastain TM, Lewczyk CM, Sharp WS, et al. 2002. Cytogenetic abnormalities in attention‐deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 41: 806–810.
17. Bearden CE, van Erp TG, Dutton RA, et al. 2007. Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex 17: 1889–1898.
18. Bender HU, Almashanu S, Steel G, et al. 2005. Functional consequences of PRODH missense mutations. Am J Hum Genet 76: 409–420.
19. Bish JP, Nguyen V, Ding L, et al. 2004. Thalamic reductions in children with chromosome 22q11.2 deletion syndrome. Neuroreport 15: 1413–1415.
20. Bish JP, Pendyal A, Ding L, et al. 2006. Specific cerebellar reductions in children with chromosome 22q11.2 deletion syndrome. Neurosci Lett 399: 245–248.
21. Boer H, Holland A, Whittington J, et al. 2002. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 359: 135–136.
22. Boks MP, de Vette MH, Sommer IE, et al. 2007. Psychiatric morbidity and X‐chromosomal origin in a Klinefelter sample. Schizophr Res 93 (1–3): 399–402.
23. Bolland E, Manzur AY, Milward TM, et al. 2000. Velocardiofacial syndrome associated with atrophy of the shoulder girdle muscles and cervicomedullary narrowing. Eur J Paediatr Neurol 4: 73–76.
24. Boot E, Booij J, Zinkstok J, et al. 2007. Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology [Epub ahead of print].
25. Botto LD, May K, Fernhoff PM et al. 2003. A population‐based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112 (1 Part 1): 101–107.
26. Campbell LE, Daly E, Toal F, et al. 2006. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel‐based morphometry MRI study. Brain 129 (Part 5): 1218–1228.
27. Chen J, Lipska BK, Halim N, et al. 2004. Functional analysis of genetic variation in catechol‐ O ‐methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807–821.
28. Chow EW, Mikulis DJ, Zipursky RB, et al. 1999. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 46: 1436–1442.
29. Chow EW, Zipursky RB, Mikulis DJ, et al. 2002. Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry 51: 208–215.
30. Correa BB, Xavier M, Guimaraes J. 2006. Association of Huntington's disease and schizophrenia‐like psychosis in a Huntington's disease pedigree. Clin Pract Epidemol Ment Health 2: 1.
31. Debbane M, Glaser B, David MK, et al. 2006a. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 84 (2/3): 187–193.
32. Debbane M, Glaser B, Gex‐Fabry M, et al. 2005. Temporal perception in velo‐cardio‐facial syndrome. Neuropsychologia 43: 1754–1762.
33. Debbane M, Schaer M, Farhoumand R, et al. 2006b. Hippocampal volume reduction in 22q11.2 deletion syndrome. Neuropsychologia 44: 2360–2365.
34. Deboer T, Wu Z, Lee A, et al. 2007. Hippocampal volume reduction in children with chromosome 22q11.2 deletion syndrome is associated with cognitive impairment. Behav Brain Funct 3: 54.
35. Dykens EM, Hodapp RM. 2007. Three steps toward improving the measurement of behavior in behavioral phenotype research. Child Adolesc Psychiatr Clin N Am 16: 617–630.
36. Egan MF, Goldberg TE, Kolachana BS, et al. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917–6922.
37. Eliez S, Barnea‐Goraly N, Schmitt JE, et al. 2002. Increased basal ganglia volumes in velo‐cardio‐facial syndrome (deletion 22q11.2). Biol Psychiatry 52: 68–70.
38. Eliez S, Blasey CM, Menon V, et al. 2001a. Functional brain imaging study of mathematical reasoning abilities in velocardiofacial syndrome (del22q11.2). Genet Med 3: 49–55.
39. Eliez S, Blasey CM, Schmitt EJ, et al. 2001c. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry 158: 447–453.
40. Eliez S, Schmitt JE, White CD, et al. 2000. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 157: 409–415.
41. Eliez S, Schmitt JE, White CD, et al. 2001b. A quantitative MRI study of posterior fossa development in velocardiofacial syndrome. Biol Psychiatry 49: 540–546.
42. Feinstein C, Eliez S, Blasey C, et al. 2002. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51: 312–318.
43. Fine SE, Weissman A, Gerdes M, et al. 2005. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35: 461–470.
44. Fischl B, Dale AM. 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97: 11050–11055.
45. Flint J. 1998. Behavioral phenotypes: conceptual and methodological issues. Am J Med Genet 81: 235–240.
46. Fombonne E, Du Mazaubrun C, Cans C, et al. 1997. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 36: 1561–1569.
47. Funke B, Pandita RK, Morrow BE. 2001. Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo‐cardio‐facial/DiGeorge syndrome on chromosome 22q11. Genomics 73: 264–271.
48. Gauthier I, Nelson CA. 2001. The development of face expertise. Curr Opin Neurobiol 11: 219–224.
49. Giedd JN, Blumenthal J, Jeffries NO, et al. 1999. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2: 861–863.
50. Glaser B, Debbane M, Hinard C, et al. 2006. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. Am J Psychiatry 163: 537–539.
51. Glaser B, Eliez S. 2007a. Cognition and the VCFS brain. In: Cutler‐Landsman D, editor. Educating children with velo‐cardio‐facial syndrome. San Diego: Plural Publishing. p 39–56.
52. Glaser B, Schaer M, Berney S, et al. 2007b. Structural changes to the fusiform gyrus: a cerebral marker for social impairments in 22q11.2 deletion syndrome? Schizophr Res 96: 82–86.
53. Golding‐Kushner KJ, Weller G, Shprintzen RJ. 1985. Velo‐cardio‐facial syndrome: language and psychological profiles. J Craniofac Genet Dev Biol 5: 259–266.
54. Goldman‐Rakic PS, Muly EC III, Williams GV. 2000. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31 (2/3): 295–301.
55. Gothelf D, Eliez S, Thompson T, et al. 2005. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8: 1500–1502.
56. Gothelf D, Feinstein C, Thompson T, et al. 2007a. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164: 663–669.
57. Gothelf D, Frisch A, Munitz H, et al. 1997. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 72: 455–461.
58. Gothelf D, Hoeft F, Hinard C, et al. 2007b. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome. Hum Brain Mapp 28: 533–542.
59. Gothelf D, Michaelovsky E, Frisch A, et al. 2007c. Association of the low‐activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol 10: 301–308.
60. Gothelf D, Penniman LC, Gu E, et al. 2007d. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Schizophr Res 96: 72–81.
61. Gothelf D, Presburger G, Zohar AH, et al. 2004. Obsessive‐compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet 126: 99–105.
62. Imamizu H, Miyauchi S, Tamada T, et al. 2000. Human cerebellar activity reflecting an acquired internal model of a new tool. Nature 403: 192–195.
63. Karayiorgou M, Morris MA, Morrow B, et al. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92 (17): 7612–7616.
64. Karoum F, Chrapusta SJ, Egan MF. 1994. 3‐Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63: 972–979.
65. Kates WR. 2007. Inroads to mechanisms of disease in child psychiatric disorders. Am J Psychiatry 164: 547–551.
66. Kates WR, Antshel KM, Abdulsabur N, et al. 2006b. A gender‐moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo‐cardio‐facial syndrome (22q11.2 deletion syndrome). Am J Med Genet B Neuropsychiatr Genet 141: 274–280.
67. Kates WR, Burnette CP, Bessette BA, et al. 2004. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol 19: 337–342.
68. Kates WR, Burnette CP, Jabs EW, et al. 2001. Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry 49: 677–684.
69. Kates WR, Krauss BR, Abdulsabur N, et al. 2007. The neural correlates of non‐spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Neuropsychologia 45: 2863–2873.
70. Kates WR, Miller AM, Abdulsabur N, et al. 2006a. Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome). J Am Acad Child Adolesc Psychiatry 45: 587–595.
71. Kraynack NC, Hostoffer RW, Robin NH. 1999. Agenesis of the corpus callosum associated with DiGeorge‐velocardiofacial syndrome: a case report and review of the literature. J Child Neurol 14: 754–756.
72. Lachman HM, Morrow B, Shprintzen R, et al. 1996. Association of codon 108/158 catechol‐ O ‐methyltransferase gene polymorphism with the psychiatric manifestations of velo‐cardio‐facial syndrome. Am J Med Genet 67: 468–472.
73. Lambe EK, Krimer LS, Goldman‐Rakic PS. 2000. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20: 8780–8787.
74. Lewis DA, Melchitzky DS, Sesack SR, et al. 2001. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432: 119–136.
75. Leyfer OT, Woodruff‐Borden J, Klein‐Tasman BP, et al. 2006. Prevalence of psychiatric disorders in 4 to 16‐year‐olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet 141: 615–622.
76. Liu H, Heath SC, Sobin C, et al. 2002. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 99: 3717–3722.
77. Machado AM, Simon TJ, Nguyen V, et al. 2007. Corpus callosum morphology and ventricular size in chromosome 22q11.2 deletion syndrome. Brain Res 1131: 197–210.
78. Mattay VS, Goldberg TE, Fera F, et al. 2003. Catechol O ‐methyltransferase val158‐met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186–6191.
79. Menon V, Mackenzie K, Rivera SM, et al. 2002. Prefrontal cortex involvement in processing incorrect arithmetic equations: evidence from event‐related fMRI. Hum Brain Mapp 16: 119–130.
80. Mitnick RJ, Bello JA, Shprintzen RJ. 1994. Brain anomalies in velo‐cardio‐facial syndrome. Am J Med Genet 54: 100–106.
81. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo‐cardio‐facial syndrome. Arch Gen Psychiatry 56: 940–945.
82. Papolos DF, Faedda GL, Veit S, et al. 1996. Bipolar spectrum disorders in patients diagnosed with velo‐cardio‐facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153: 1541–1547.
83. Passarotti A, Paul B, Bussiere J, et al. 2003. The development of face and location processing: an fMRI study. Dev Sci 6: 100–117.
84. Paterlini M, Zakharenko SS, Lai WS et al. 2005. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia‐related phenotypes in mice. Nat Neurosci 8: 1586–1594.
85. Poulton R, Caspi A, Moffitt TE, et al. 2000. Children's self‐reported psychotic symptoms and adult schizophreniform disorder: a 15‐year longitudinal study. Arch Gen Psychiatry 57: 1053–1058.
86. Raux G, Bumsel E, Hecketsweiler B, et al. 2007. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 16: 83–91.
87. Robin NH, Taylor CJ, McDonald‐McGinn DM, et al. 2006. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A 140: 2416–2425.
88. Russell HF, Wallis D, Mazzocco MM, et al. 2006. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. Disabil Rehabil Psychol 31: 945–955.
89. Schaer M, Bach Cuadra M, Tamarit L, et al. A surface‐based approach to quantify local cortical gyrification. IEEE Trans Med Imag (in press).
90. Schaer M, Schmitt JE, Glaser B, et al. 2006. Abnormal patterns of cortical gyrification in velo‐cardio‐facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res 146: 1–11.
91. Scherf S, Behrmann M, Humphreys K, et al. 2007. Visual category‐selectivity for faces, places and objects emerges along different developmental trajectories. Dev Sci 10: F15–F30.
92. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1–57.
93. Shashi V, Muddasani S, Santos CC, et al. 2004. Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage 21: 1399–1406.
94. Shenton ME, Dickey CC, Frumin M, et al. 2001. A review of MRI findings in schizophrenia. Schizophr Res 49 (1/2): 1–52.
95. Shprintzen RJ, Goldberg R, Golding‐Kushner KJ, et al. 1992. Late‐onset psychosis in the velo‐cardio‐facial syndrome. Am J Med Genet 42: 141–142.
96. Shprintzen RJ, Goldberg RB, Lewin ML, et al. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo‐cardio‐facial syndrome. Cleft Palate J 15: 56–62.
97. Simon TJ, Ding L, Bish JP, et al. 2005. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 25: 169–180.
98. Sobin C, Monk SH, Kiley‐Brabeck K, et al. 2006. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov Disord 21: 2082–2089.
99. Sowell ER, Thompson PM, Tessner KD, et al. 2001. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci 21: 8819–8829.
100. Sporn A, Addington A, Reiss AL, et al. 2004. 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry 9: 225–226.
101. Sullivan K, Hatton D, Hammer J, et al. 2006. ADHD symptoms in children with FXS. Am J Med Genet A 140: 2275–2288.
102. Sun H, Yushkevich PA, Zhang H, et al. Shape‐based normalization of the corpus callosum for DTI connectivity analysis. IEEE Trans Med Imag (in press).
103. Swillen A. 2006. Cognitive development in children and adolescents with del22q11.2. In the Annual Meeting of the Society for the Study of Behavioral Phenotypes, Dublin, Ireland.
104. Swillen A, Devriendt K, Legius E, et al. 1997. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34: 453–458.
105. Swillen A, Devriendt K, Legius E, et al. 1999. The behavioural phenotype in velo‐cardio‐facial syndrome (VCFS): from infancy to adolescence. Genet Couns 10: 79–88.
106. Tamm L, Menon V, Reiss AL. 2002. Maturation of brain function associated with response inhibition. J Am Acad Child Adolesc Psychiatry 41: 1231–1238.
107. Thompson PM, Hayashi KM, Sowell ER, et al. 2004. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 ( Suppl 1): S2–S18.
108. van Amelsvoort T, Daly E, Henry J, et al. 2004. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry 61: 1085–1096.
109. van Amelsvoort T, Daly E, Robertson D, et al. 2001. Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo‐cardio‐facial syndrome. Br J Psychiatry 178: 412–419.
110. van Amelsvoort T, Schmitz N, Daly E, et al. 2006. Processing facial emotions in adults with velo‐cardio‐facial syndrome: functional magnetic resonance imaging. Br J Psychiatry 189: 560–561.
111. van Amelsvoort T, Zinkstok J, Figee M, et al. 2008. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo‐cardio‐facial syndrome. Psychol Med 38: 89–100.
112. Vorstman JA, Morcus ME, Duijff SN, et al. 2006. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45: 1104–1113.
113. Wigren M, Hansen S. 2005. ADHD symptoms and insistence on sameness in Prader‐Willi syndrome. J Intellect Disabil Res 49 (Part 6): 449–456.
114. Zafeiriou DI, Ververi A, Vargiami E. 2007. Childhood autism and associated comorbidities. Brain Dev 29: 257–272.